Woman at desk with tablet

Resources

Here you will find a range of media specific resources including our latest and archived press releases, and our photo and video library.

15 January 2022 Update - GSK Consumer Healthcare
13 January 2022 GSK and Vir submit Emergency Use Authorization application to FDA for intramuscular administration of sotrovimab for the early treatment of COVID-19
11 January 2022 GSK and Vir Biotechnology announce United States government agreement to purchase additional supply of sotrovimab, authorised for the early treatment of COVID-19
20 December 2021 ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention
15 December 2021 GSK and Sanofi announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of phase III trial per independent Monitoring Board recommendation

GSK US on Twitter

GSKUS @GSKUS

#News for #investors and #media: Today, in partnership with @Vir_Biotech, we’re proud to announce the United States government will purchase additional supply of an investigational monoclonal antibody for the early treatment of #COVID19. Read more here: gsk.to/33kwsYf
about 4 days ago
GSKUS @GSKUS

#Investors and #Media Watch Hal Barron, our Chief Scientific Officer and President, R&D, on an @endpts #JPM22 panel tomorrow at 1330 EST / 1030 PST / 1830 GMT discussing key pharma R&D trends for 2022 – register here: gsk.to/3zGP2WC at #JPM22
about 5 days ago

Media links